Weekly Stock Review: MaiDe Medical (688310) repurchased shares worth 25.64 million yuan, accounting for 0.96% of the total share capital.

As of the close on April 3, 2026, Mindray Medical (688310) closed at 14.76 yuan, down 3.47% from last week’s 15.29 yuan. This week, Mindray Medical’s intraday high on April 1 was 15.74 yuan. On April 3, the intraday low was 14.52 yuan. Mindray Medical’s current latest total market value is 2.45B yuan; in the automation equipment sector it ranks 75/79 by market value, and in the A-share market across both cities it ranks 4855/5193 by market value.

Key focus this week

  • Company announcement roundup: As of March 31, 2026, the company has cumulatively repurchased 1,600,082 shares, with a total payment of 25,639,888.96 yuan
  • Company announcement roundup: In March 2026 alone, the company repurchased 303,030 shares, with funds paid of 4,979,684.17 yuan
  • Company announcement roundup: The repurchase price range was 15.69 yuan/share to 16.50 yuan/share, which is consistent with the established plan

Company announcement roundup

Mindray Medical Industrial Equipment Co., Ltd. first disclosed its share repurchase plan on December 13, 2025. The repurchase period runs from December 30, 2025 to December 29, 2026. The company plans to repurchase an amount of 20 million yuan to 40 million yuan, to reduce registered capital. As of March 31, 2026, the company has cumulatively repurchased 1,600,082 shares, accounting for 0.9626% of the total share capital, with a cumulative payment of 25,639,888.96 yuan. The repurchase price range was 15.69 yuan/share to 16.50 yuan/share. In March 2026 alone, it repurchased 303,030 shares, and paid 4,979,684.17 yuan. This repurchase complies with relevant regulations and the company’s plan requirements.

The above content has been compiled by Securities Star from publicly available information and generated by an AI algorithm (网信算备310104345710301240019号); it does not constitute investment advice.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin